Innovation
Blue Bees Therapeutics: boosting immune cells to treat cancer
… someone who could help him develop a structure," recalls Philippe Berthon, CEO of the start-up. Working with Nabil … What's happening in France right now is spectacular," says Philippe Berthon. He continues: "We have secured close to … will enter regulatory preclinical development. According to Philippe Berthon, "This stage will last about two years and …Published on: